𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C

✍ Scribed by John P Bate; Anton J Colman; Peter J Frost; David R Shaw; Hugh AJ Harley

Book ID
108953720
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
256 KB
Volume
25
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence and impact of occult hepatiti
Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin
✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; AgnΓ¨s Plages; Al πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

Persistence of hepatitis C virus in pati
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C
✍ Marek Radkowski; Juan F. Gallegos-Orozco; Joanna Jablonska; Thomas V. Colby; Boz πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 156 KB πŸ‘ 1 views

It is unclear whether the current antiviral treatment for chronic hepatitis C virus (HCV) infection results in complete elimination of the virus, or whether small quantities of virus persist. Our study group comprised 17 patients with chronic HCV who had sustained virological response (SVR) after in

High prevalence of serological markers o
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
✍ Bernard D. Clifford; Daniel Donahue; Lynda Smith; Edward Cable; Brigit Luttig; M πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 851 KB

The advent of specific antiviral therapy for chronic hepatitis C has increased the importance of establishing the correct etiology of chronic hepatitis in patients, especially because interferon alfa (IFN-a) has been reported to exacerbate autoimmune hepatitis (AIH), whereas corticosteroids increase